Tolperisone: Difference between revisions
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
{{Drugbox | {{Drugbox | ||
|IUPAC_name = 2-methyl-1-(4-methylphenyl)-3-(1-piperidyl)propan-1-one | | IUPAC_name = 2-methyl-1-(4-methylphenyl)-3-(1-piperidyl)propan-1-one | ||
| image=Tolperisone.svg | | image=Tolperisone.svg | ||
| width = 120 | | width = 120 | ||
| Line 31: | Line 31: | ||
* {{cite journal | author = Ribi C, Vermeulen C, Hauser C | title = Anaphylactic reactions to tolperisone (Mydocalm). | journal = Swiss Med Wkly | volume = 133 | issue = 25-26 | pages = 369-71 | year = 2003 | id = PMID 12947534}} | * {{cite journal | author = Ribi C, Vermeulen C, Hauser C | title = Anaphylactic reactions to tolperisone (Mydocalm). | journal = Swiss Med Wkly | volume = 133 | issue = 25-26 | pages = 369-71 | year = 2003 | id = PMID 12947534}} | ||
{{Muscle relaxants}} | |||
[[Category:Drug]] | |||
Revision as of 14:41, 8 April 2015
| File:Tolperisone.svg | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C16H23NO |
| Molar mass | 245.36 g/mol |
|
WikiDoc Resources for Tolperisone |
|
Articles |
|---|
|
Most recent articles on Tolperisone Most cited articles on Tolperisone |
|
Media |
|
Powerpoint slides on Tolperisone |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Tolperisone at Clinical Trials.gov Clinical Trials on Tolperisone at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Tolperisone
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Tolperisone Discussion groups on Tolperisone Patient Handouts on Tolperisone Directions to Hospitals Treating Tolperisone Risk calculators and risk factors for Tolperisone
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Tolperisone |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Tolperisone, a piperidine derivative, is a centrally acting muscle relaxant. Brand names include Mydocalm and Mydeton.
External links
- Hofer D, Lohberger B, Steinecker B, Schmidt K, Quasthoff S, Schreibmayer W (2006). "A comparative study of the action of tolperisone on seven different voltage dependent sodium channel isoforms". Eur J Pharmacol. 538 (1–3): 5–14. PMID 16650844.
- Kocsis P, Farkas S, Fodor L, Bielik N, Thán M, Kolok S, Gere A, Csejtei M, Tarnawa I (2005). "Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels". J Pharmacol Exp Ther. 315 (3): 1237–46. PMID 16126840.
- Ribi C, Vermeulen C, Hauser C (2003). "Anaphylactic reactions to tolperisone (Mydocalm)". Swiss Med Wkly. 133 (25–26): 369–71. PMID 12947534.
- Pages with script errors
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- CS1 maint: Multiple names: authors list
- Drug